09 Sep - 2 min read

Cautionary Announcement – API Business

Cautionary Announcement – API Business

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings” or the “Company”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)


CAUTIONARY ANNOUNCEMENT – API BUSINESS


Following the receipt of two material unsolicited offers for its active pharmaceutical ingredient business
(“API Business”)(1), Aspen has decided to embark on a structured process to facilitate offers for all or parts of
its API Business from those parties that submitted the unsolicited offers and other selected interested
parties. This will enable Aspen to make a full and informed assessment of what it considers to be in the best
interests of Aspen, the management and employees of its API Business and other stakeholders.

The outcome of this structured process may have a material effect on the price of the Company's securities.
Accordingly, shareholders are advised to exercise caution when dealing in the Company’s securities.

Footnote:
(1) Comprising the Chemicals and Biochem segments of Aspen’s Manufacturing operations, situated in the Netherlands,
    South Africa and the United States.


Durban
09 September 2021

Sponsor
Investec Bank Limited






Date: 09-09-2021 08:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Aspen Pharmacare Holdings Limited (JSE:APN) when you join Listcorp.